Search Results - "Meluch, Anthony A"

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer by SCHER, Howard I, XIAOYU JIA, MELUCH, Anthony A, NORDQUIST, Luke T, VENNER, Peter M, HEIDENREICH, Axel, CHU, Luis, HELLER, Glenn, CHI, Kim, DE WIT, Ronald, BERRY, William R, ALBERS, Peter, HENICK, Brian, WATERHOUSE, David, RUETHER, Dean J, ROSEN, Peter J

“…To compare the efficacy and safety of docetaxel plus high-dose calcitriol (DN-101) to docetaxel plus prednisone in an open-label phase III trial. Nine hundred…”
Get full text

Phase I/II Trial of Preoperative Oxaliplatin, Docetaxel, and Capecitabine With Concurrent Radiation Therapy in Localized Carcinoma of the Esophagus or Gastroesophageal Junction by SPIGEL, David R, GRECO, F. Anthony, MELUCH, Anthony A, LANE, Cassie M, FARLEY, Cynthia, GRAY, James R, CLARK, Bobby L, BURRIS, Howard A, HAINSWORTH, John D

“…Preoperative chemoradiotherapy is a primary treatment option for patients with resectable esophageal cancer. Combination regimens using newer agents may…”
Get full text

Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases by MATHEW, Paul, THALL, Peter F, TU, Shi-Ming, MELUCH, Anthony A, SMITH, Lon, COHEN, Lorenzo, KIM, Sun-Jin, TRONCOSO, Patricia, FIDLER, Isaiah J, LOGOTHETIS, Christopher J, BUCANA, Corazon D, OH, William K, MORRIS, Michael J, JONES, Donnah M, JOHNSON, Marcella M, WEN, Sijin, PAGLIARO, Lance C, TANNIR, Nizar M

“…Purpose: To further assess preclinical and early clinical evidence that imatinib mesylate, a platelet-derived growth factor receptor (PDGFR) inhibitor,…”
Get full text

Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network by MELUCH, Anthony A, GRECO, F. Anthony, BURRIS, Howard A, O'ROURKE, Timothy, ORTEGA, Gregory, STEIS, Ronald G, MORRISSEY, Lisa H, JOHNSON, Valerie, HAINSWORTH, John D

“…To evaluate the toxicity and efficacy of combination chemotherapy with paclitaxel and gemcitabine in patients with advanced transitional-cell carcinoma of the…”
Get full text

BILATERAL UVEAL METASTASES SECONDARY TO PROSTATE ADENOCARCINOMA by Cochran, Katherine J, Gray, James R, Meluch, Anthony A, Reichstein, David A

“…To report a patient with bilateral uveal metastases secondary to previously quiescent prostate adenocarcinoma with a 22-month follow-up. Retrospective chart…”
Get full text

Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium : A phase II trial of the minnie pearl cancer research network by HAINSWORTH, John D, MELUCH, Anthony A, LITCHY, Sharlene, SCHNELL, Frederick M, BEARDEN, James D, YOST, Kathleen, GRECO, F. Anthony

“…Abstract BACKGROUND The objective of the current study was to evaluate the efficacy and toxicity of combination chemotherapy with paclitaxel, carboplatin, and…”
Get full text

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: Final results of a Minnie Pearl Cancer Research Network phase II trial by MELUCH, Anthony A, GRECO, F. Anthony, HAINSWORTH, John D, GRAY, James R, THOMAS, Melodie, SUTTON, Valerie M, DAVIS, J. Lucian, KALMAN, Leonard A, SHAFFER, Don W, YOST, Kathleen, RINALDI, David A

“…This phase II study was designed to determine the feasibility, toxicity, and therapeutic efficacy of a novel outpatient combined-modality preoperative regimen…”
Get full text

Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial by Hainsworth, John D, Meluch, Anthony A, Spigel, David R, Barton, John, Simons, Lisa, Meng, Christina, Gould, Bruce, Greco, F. Anthony

“…Abstract Background Docetaxel is currently the standard first-line treatment in patients with hormone-refractory prostate cancer (HRPC). Bortezomib, the first…”
Get full text

Single Agent Vinflunine in the Salvage Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Trial of the Sarah Cannon Research Consortium by Hainsworth, John D., Meluch, Anthony A., Lane, Cassie M., Spigel, David R., Burris, Howard A., Gandhi, Jitendra G., Crane, Edward J., Stipanov, Michael A., Greco, F. Anthony

“…ABSTRACT Patients with metastatic prostate cancer resistant to hormones and docetaxel were treated with vinflunine (320 mg/m2 every 21 days), a new vinca…”
Get full text

Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer by Burris, Howard A., Jones, Suzanne F., Shipley, Dianna, Meluch, Anthony A., Greco, F. Anthony, Barton, John H., Yardley, Denise A., Hainsworth, John D.

Get full text

Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer by Burris, Howard A., Jones, Suzanne F., Shipley, Dianna, Meluch, Anthony A., Greco, F. Anthony, Barton, John H., Yardley, Denise A., Hainsworth, John D.

“…ABSTRACT We examined the toxicity/efficacy of capecitabine with thalidomide, administered over 21-day cycles, in 24 previously treated metastatic breast cancer…”
Get full text

Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a phase II trial by HAINSWORTH, John D, BURRIS, Howard A, MELUCH, Anthony A, BAKER, Margaret N, MORRISSEY, Lisa H, GRECO, F. Anthony

“…The purpose of this study was to evaluate the feasibility, toxicity, and efficacy of the combination of paclitaxel, carboplatin, and long-term continuous…”
Get full text

Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium by Hainsworth, John D., Meluch, Anthony A., Litchy, Sharlene, Schnell, Frederick M., Bearden, James D., Yost, Kathleen, Greco, F. Anthony

“…BACKGROUND The objective of the current study was to evaluate the efficacy and toxicity of combination chemotherapy with paclitaxel, carboplatin, and…”
Get full text

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: Results of a minnie pearl cancer research network phase II trial by MELUCH, Anthony A, GRECO, F. Anthony, MORRISSEY, Lisa H, RAEFSKY, Eric L, STEIS, Ronald G, BUTTS, James A, HAINSWORTH, John D

“…The objective of the current study was to evaluate the efficacy and toxicity of weekly paclitaxel, oral etoposide, and estramustine phosphate in the treatment…”
Get full text

Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial by Hainsworth, John D., Yardley, Denise A., Spigel, David R., Meluch, Anthony A., Rinaldi, David, Schnell, Frederick M., Greco, F. Anthony

“…Background: Taxanes and anthracyclines are the two most active classes of cytotoxic agents in the treatment of patients with metastatic breast cancer…”
Get full text

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: A phase II trial of the minnie pearl cancer research network by HAINSWORTH, John D, MELUCH, Anthony A, GRECO, F. Anthony, MCCLURKAN, Suzanne, GRAY, James R, STROUP, Steven L, BURRIS, Howard A, YARDLEY, Denise A, BRADOF, James E, YOST, Kathleen, ELLIS, James K

“…The purpose of this study was to evaluate the feasibility, toxicity, and efficacy of a novel combined-modality treatment for patients with locally advanced…”
Get full text

Weekly Docetaxel/Estramustine Phosphate in Patients with Increasing Serum Prostate-Specific Antigen Levels After Primary Treatment for Prostate Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network by Hainsworth, John D., Meluch, Anthony A., Spigel, David R., Yost, Kathleen, Meng, Christina, Greco, F. Anthony

“…Docetaxel alone or in combination with estramustine prolongs survival in patients with metastatic hormone-refractory prostate cancer. The role of chemotherapy…”
Get full text

A Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide, and Dexamethasone (ERd) in the Induction, Consolidation, and Maintenance Treatment of Transplant-Eligible Patients Newly Diagnosed with Multiple Myeloma (MM) by Berdeja, Jesus G., Gregory, Tara K., Kambhampati, Suman, Anz, Bertrand M., Tarantolo, Stefano R., Meluch, Anthony A., Matous, Jeffrey V.

“…Background: The introduction of novel agents such as proteasome inhibitors (PI) and immunomodulatory drugs (IMiDs) with and without corticosteroids has…”
Get full text

BILATERAL UVEAL METASTASES SECONDARY TO PROSTATE ADENOCARCINOMA by Cochran, Katherine J., Gray, James R., Meluch, Anthony A., Reichstein, David A.

Get full text

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone‐refractory prostate carcinoma by Meluch, Anthony A., Greco, F. Anthony, Morrissey, Lisa H., Raefsky, Eric L., Steis, Ronald G., Butts, James A., Hainsworth, John D.

“…BACKGROUND The objective of the current study was to evaluate the efficacy and toxicity of weekly paclitaxel, oral etoposide, and estramustine phosphate in the…”
Get full text